Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity. - Wikidata - awgldk - TriplyDB

Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.

Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.

http://www.wikidata.org/entity/Q37978886

about

Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome.C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study.Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart Failure.β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure Insulin resistance and heart failure: molecular mechanisms Sympathetically-mediated cardiac responses to isolated muscle metaboreflex activation following exercise are modulated by body position in humans.Management of Supraventricular Tachycardia in Infants.Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.Neurotransmitter Switching Coupled to β-Adrenergic Signaling in Sympathetic Neurons in Prehypertensive States.

P2860

Q26767412-A53CF7BF-A63D-40F9-BB5E-1820970A2898 Q34254761-E7CCB1FA-F332-4A6A-AD45-B84964F5ECA4 Q36947760-3840F143-D738-4028-9DEC-99A4FE1182BB Q37027129-E7D62E86-7201-4804-9B12-AD0EB6014149 Q37140401-D43E7891-121A-4303-876E-9153E788DB26 Q37142802-8685B383-7F0A-4A48-A37F-53792B7926AC Q38045550-3DB4FAEE-D3B4-47B6-8D04-FF89B4EC15E6 Q49917691-8988FF15-5B02-485F-B996-5169B275A0AF Q50238151-8DD750C3-626C-4463-A7D6-5CEC8FA68041 Q52686636-EFB405F7-0E37-4B49-8321-783A22FA202C Q55434412-3F3BE2D9-9256-4F91-8020-1B8116145D61

P2860

Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.

http://www.wikidata.org/entity/Q37978886

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cardio-selective beta-blocker: ...... nfluence on exercise capacity.

@en

Cardio-selective beta-blocker: ...... nfluence on exercise capacity.

@nl

type

label

Cardio-selective beta-blocker: ...... nfluence on exercise capacity.

@en

Cardio-selective beta-blocker: ...... nfluence on exercise capacity.

@nl

prefLabel

Cardio-selective beta-blocker: ...... nfluence on exercise capacity.

@en

Cardio-selective beta-blocker: ...... nfluence on exercise capacity.

@nl

P1433

Q37978886-EA5178AC-79D2-41B9-910B-BE2CE323AEB1

P1476

Q37978886-372EFC6A-0150-4275-98AE-8BCBD75C2B72

P2093

Q37978886-0FE28B3D-AB0E-474F-B6FB-00D2F0BD003D

Q37978886-25F4FAB1-19E1-4C2A-AE8C-0532FF6019C2

Q37978886-F349274E-C56C-4154-87C1-B777E90BDFDD

P2860

Q37978886-054ADAF7-7AE6-431A-B564-38648E64DB69

Q37978886-0A48B529-FA54-4C42-8D1D-F20B858AD506

Q37978886-11F84C77-2A4A-4EA6-9ADA-5465C48231C1

Q37978886-1286BD0D-1F25-4A99-835B-8C83909C8BDC

Q37978886-190073B1-4A34-4ADD-A4C2-1FAFFFF26A8E

Q37978886-22F9B1CE-4BE1-46DF-9F95-A6B7AFB56A5D

Q37978886-256214AF-0C19-4772-ABA5-178B6084E253

Q37978886-2EF7A817-93D6-4474-B610-B9502A5BE946

Q37978886-33A44DED-783F-4BB8-9EFC-736118EDD186

Q37978886-33EAFA6F-214E-4387-9340-875E755463AE

P304

Q37978886-C2B4F638-840D-4362-8359-DD0494394EB7

P31

Q37978886-F306ED0D-ADC7-45F5-B6EC-373F179B5459

P356

Q37978886-AB025896-0F1A-4BB1-9050-F928B4875870

P433

Q37978886-B11F723C-C256-4CC1-8B57-0FA7C021D4F4

P478

Q37978886-358FCCBC-05D7-48DF-926E-6A6084A8D05B

P577

Q37978886-A275CA7A-9BF8-418A-BCCB-91E80232633D

P698

Q37978886-25EE2B33-83C1-4464-92F5-69B45A2291F8

P921

Q37978886-D5008777-E1CE-4D27-B916-04ED608BD2E1

P356

J.1755-5922.2011.00306.X

P1433

Cardiovascular Therapeutics

P1476

Cardio-selective beta-blocker: ...... nfluence on exercise capacity.

@en

P2093

Dennis Ladage

http://www.w3.org/2001/XMLSchema#string

Klara Brixius

http://www.w3.org/2001/XMLSchema#string

Robert H G Schwinger

http://www.w3.org/2001/XMLSchema#string

P2860

Pheochromocytomas and secreting paragangliomas

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

beta Blockade after myocardial infarction: systematic review and meta regression analysis

The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors

A comparison of the beta1-selectivity of three beta1-selective beta-blockers

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients

The role of the new beta-blockers in treating cardiovascular disease

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise.

beta-adrenergic receptor blockade in chronic heart failure.

P304

76-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5922.2011.00306.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22279967

http://www.w3.org/2001/XMLSchema#string

P921